These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36634459)

  • 1. Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
    Vulsteke JB; Smith V; Bonroy C; Derua R; Blockmans D; De Haes P; Vanderschueren S; Lenaerts JL; Claeys KG; Wuyts WA; Verschueren P; Vanhandsaeme G; Piette Y; De Langhe E; Bossuyt X
    J Autoimmun; 2023 Feb; 135():102988. PubMed ID: 36634459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis.
    Perurena-Prieto J; Viñas-Giménez L; Sanz-Martínez MT; Selva-O'Callaghan A; Callejas-Moraga EL; Colobran R; Guillén-Del-Castillo A; Simeón-Aznar CP
    Rheumatology (Oxford); 2024 Aug; 63(8):2278-2283. PubMed ID: 37769243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies targeting telomere-associated proteins in systemic sclerosis.
    Adler BL; Boin F; Wolters PJ; Bingham CO; Shah AA; Greider C; Casciola-Rosen L; Rosen A
    Ann Rheum Dis; 2021 Jul; 80(7):912-919. PubMed ID: 33495152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis.
    Vulsteke JB; Smith V; Bonroy C; Lenaerts JL; Derua R; Wuyts WA; Blockmans D; De Haes P; Piette Y; De Langhe E; Bossuyt X
    J Autoimmun; 2023 Sep; 139():103056. PubMed ID: 37302272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.
    Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L
    Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13).
    Bossuyt X; Vulsteke JB; Van Elslande J; Boon L; Wuyts G; Willebrords S; Frans G; Geukens N; Carpentier S; Tejpar S; Wildiers H; Blockmans D; De Langhe E; Vermeersch P; Derua R
    Autoimmun Rev; 2023 Apr; 22(4):103288. PubMed ID: 36738952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.
    Johnson ME; Grassetti AV; Taroni JN; Lyons SM; Schweppe D; Gordon JK; Spiera RF; Lafyatis R; Anderson PJ; Gerber SA; Whitfield ML
    Arthritis Res Ther; 2016 Jan; 18():27. PubMed ID: 26801089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
    Betteridge ZE; Woodhead F; Lu H; Shaddick G; Bunn CC; Denton CP; Abraham DJ; du Bois RM; Lewis M; Wells AU; McHugh NJ
    Arthritis Rheumatol; 2016 Nov; 68(11):2778-2783. PubMed ID: 27273608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
    Kaji K; Fertig N; Medsger TA; Satoh T; Hoshino K; Hamaguchi Y; Hasegawa M; Lucas M; Schnure A; Ogawa F; Sato S; Takehara K; Fujimoto M; Kuwana M
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome.
    Matsuda KM; Kotani H; Yamaguchi K; Ono C; Okumura T; Ogawa K; Miya A; Sato A; Uchino R; Yumi M; Matsunaka H; Kono M; Norimatsu Y; Hisamoto T; Kawanabe R; Kuzumi A; Fukasawa T; Yoshizaki-Ogawa A; Okamura T; Shoda H; Fujio K; Matsushita T; Goshima N; Sato S; Yoshizaki A
    Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38290780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly.
    Venteicher AS; Meng Z; Mason PJ; Veenstra TD; Artandi SE
    Cell; 2008 Mar; 132(6):945-57. PubMed ID: 18358808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrosome proteins: a major class of autoantigens in scleroderma.
    Gavanescu I; Vazquez-Abad D; McCauley J; Senecal JL; Doxsey S
    J Clin Immunol; 1999 May; 19(3):166-71. PubMed ID: 10404401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.
    Montecucco C; Caporali R; Cobianchi F; Biamonti G
    Arthritis Rheum; 1996 Oct; 39(10):1669-76. PubMed ID: 8843857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies.
    Vulsteke JB; Derua R; Dubucquoi S; Coutant F; Sanges S; Goncalves D; Wuyts G; De Haes P; Blockmans D; Wuyts WA; Claeys KG; De Langhe E; Fabien N; Bossuyt X
    Ann Rheum Dis; 2023 Apr; 82(4):546-555. PubMed ID: 36572507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of telomerase by telomeric proteins.
    Smogorzewska A; de Lange T
    Annu Rev Biochem; 2004; 73():177-208. PubMed ID: 15189140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
    Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
    Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
    Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
    J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.